Results 111 to 120 of about 34,440,044 (184)

Impact of Glucagon-Like Peptide-1 Receptor Agonists on Mental Health: A Systematic Review of Psychiatric Safety and Antidepressant Potential. [PDF]

Cureus
Quadir A, Devi R, Jad Allah B, Haider A, Shaikh SS, Botsa KN.   +5 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Reproductive Health: A Narrative Review for Obstetrician-Gynecologists. [PDF]

Cureus
Almaradweh S, Mousa E.
europepmc   +1 more source

The emerging role of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: Therapeutic potential and challenges. [PDF]

Indian J Ophthalmol
Thandampallayam M, Abusamra K, Kini A, Vasireddy RP.   +3 more
europepmc   +1 more source

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study. [PDF]

World Psychiatry
Keshen A, Koning E, Allison KC, Amaro A, Bartel S, Belliveau P, Boniferro L, Brar S, Butalia S, Bulik CM, Chao AM, Couturier J, Dennis K, Dixon L, El-Ziftawi D, Gao C, Gamberg S, Goldstone AP, Dalle Grave R, Guerdjikova AI, Halliday TM, Hahn M, Harris A, Himmerich H, Horton WB, Jericho M, Langman B, Lightbody A, Klein DA, Mayer LES, McElroy SL, Mindrum M, Peiper NC, Price C, Raffoul A, Richards J, Schaefer LM, Steinglass J, Taylor VH, Tchang BG, Trappenberg N, Walsh BT, Weintraub MA, White A, Wnuk S.   +44 more
europepmc   +1 more source

A systematic review and meta-analyses of glucagon-like peptide-1 receptor agonists in acute myocardial infarction. [PDF]

Egypt Heart J
Bhullar JK, Bahekar A.
europepmc   +1 more source

The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity. [PDF]

Hypertens Res
Koyanagi Y, Iigaya K, Ikeda K, Onimaru H, Izumizaki M.   +4 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis. [PDF]

Adv Ther
Panou T, Gouveri E, Popovic DS, Papanas N.   +3 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation. [PDF]

J Am Chem Soc
Fallot LB, Anderson CA, Pinc JR, Stevenson A, Schleck MC, Hawryschuk E, Li OZ, Palchak JC, Toole JR, Kubiak Ii RW, Dear AJ, Michaels TCT, Limbocker R.   +12 more
europepmc   +1 more source